Dexcom
Rachel Mullen is an experienced legal operations professional currently serving as Director of Legal Operations at Dexcom since September 2022. Previously, Rachel held the position of Senior Manager of Legal Operations at Resilience, where leadership was provided to a growing legal department in the biopharmaceutical sector. Rachel's earlier tenure at Thermo Fisher Scientific included roles as Manager of Legal Operations and License Compliance Specialist, focusing on contract management and compliance across a substantial portfolio of agreements. At the Salk Institute for Biological Studies, Rachel progressed from Marketing Associate to Licensing Associate, overseeing biotechnology inventions and managing licensing negotiations. Rachel holds a Master of Business Science in Applied Life Sciences from Keck Graduate Institute and a Bachelor of Science in Biopsychology from UC Santa Barbara.
Dexcom
43 followers
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes.